NCI operational task order
Ended Awarded Last action
- Contract number
- 75N91019F00129
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $432,416,292
Award facts
- Opportunity
-
- N02CO7240681 Solicitation number
- Contract value 100% obligated
- $432,416,291.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$66,566 | |
| Other Administrative Action | -$4,882,212 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $2,150,259 | |
| Other Administrative Action | $10,574,155 | |
| Funding Only Action | $4,550,785 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $22,416,036 | |
| Funding Only Action | $46,000,000 | |
| Other Administrative Action | -$393,000 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $95,139,014 | |
| Original award | $256,927,820 |
Show all 18
About this award
The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on August 31, 2019, with a ceiling value of $432.4 million for ongoing National Cancer Institute operational support, including COVID-19 case study initiation under project YT 20-144.
Leidos Biomedical Research Inc. operates as a Federally Funded Research and Development Center (FFRDC) contractor for the National Cancer Institute and National Institutes of Health, providing biomedical research and facilities support services. Place of performance is Frederick, Maryland. The order is structured as cost-plus-fixed-fee and has an ultimate completion date of May 21, 2026. The work encompasses comprehensive research, development, and operational support across multiple scientific domains including medical research, clinical trials, facility management, and advanced technological solutions.
Quick answers
Who was awarded contract 75N91019F00129?
75N91019F00129 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on August 31, 2019.
How much is contract 75N91019F00129 worth?
The government has obligated $432,416,292 on 75N91019F00129.
Is contract 75N91019F00129 an order under another contract?
Yes. 75N91019F00129 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91019F00129 competed?
The extent of competition for 75N91019F00129 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award